— Know what they know.
Not Investment Advice

LUNG NASDAQ

Pulmonx Corporation
1W: +14.9% 1M: +18.5% 3M: +2.0% YTD: -33.0% 1Y: -54.0% 3Y: -87.9% 5Y: -95.9%
$1.55
+0.01 (+0.65%)
 
Weekly Expected Move ±7.7%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Medical - Devices · Alpha Radar Buy · Power 64 · $65.5M mcap · 37M float · 1.51% daily turnover · Short 42% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE
58.4 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: -101.6%  ·  5Y Avg: -69.2%
Cost Advantage
49
Intangibles
72
Switching Cost
57
Network Effect
74
Scale
35
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. LUNG has a Narrow competitive edge (58.4/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Network Effects. Negative ROIC of -101.6% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$0
Low
$3
Avg Target
$3
High
Based on 2 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 4Hold: 4Sell: 1Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$3.25
Analysts2
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2025-10-28 Lake Street Initiated $4 +65.4% $2.42
2025-07-31 Piper Sandler Jason Bednar $10 $2 -8 -20.6% $3.15
2024-10-31 Piper Sandler Jason Bednar Initiated $10 +47.3% $6.79
2024-08-01 Canaccord Genuity William Plovanic Initiated $16 +115.6% $7.42
2024-06-04 Loop Capital Markets Frank Takkinen Initiated $12 +71.4% $7.00
2023-01-06 Morgan Stanley $19 $10 -10 +20.6% $7.88
2022-12-12 Wells Fargo Initiated $6 -3.5% $6.22
2022-12-12 Citigroup Initiated $10 +70.1% $5.88
2022-07-18 Stifel Nicolaus Initiated $20 +22.2% $16.37
2022-07-15 Morgan Stanley Initiated $19 +17.2% $16.20

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C-
May 22, 2026
DCF
1
ROE
1
ROA
1
D/E
1
P/E
1
P/B
4
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. LUNG receives an overall rating of C-. Strongest factors: P/B (4/5). Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5).
Rating Change History
DateFromTo
2026-03-06 D+ C-
2026-03-04 C- D+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

25 Grade D
Profitability
20
Balance Sheet
39
Earnings Quality
36
Growth
56
Value
41
Momentum
55
Safety
0
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. LUNG scores highest in Growth (56/100) and lowest in Safety (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-5.05
Distress Zone
Piotroski F-Score
3/9
Beneish M-Score
-3.26
Unlikely Manipulator
Ohlson O-Score
-4.35
Bankruptcy prob: 1.3%
Low Risk
Credit Rating
B
Score: 27.7/100
Trend: Deteriorating
Earnings Quality
OCF/NI: 0.55x
Accruals: -16.4%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. LUNG scores -5.05, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. LUNG scores 3/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. LUNG's score of -3.26 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. LUNG's implied 1.3% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. LUNG receives an estimated rating of B (score: 27.7/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-1.22x
PEG
-0.12x
P/S
0.74x
P/B
1.42x
P/FCF
-1.83x
P/OCF
EV/EBITDA
-0.82x
EV/Revenue
0.46x
EV/EBIT
-0.81x
EV/FCF
-1.37x
Earnings Yield
-98.45%
FCF Yield
-54.50%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. LUNG currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.012
NI / EBT
×
Interest Burden
1.050
EBT / EBIT
×
EBIT Margin
-0.566
EBIT / Rev
×
Asset Turnover
0.606
Rev / Assets
×
Equity Multiplier
2.088
Assets / Equity
=
ROE
-76.1%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. LUNG's ROE of -76.1% is driven by Asset Turnover (0.606), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.01 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1417 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$1.55
Median 1Y
$0.61
5th Pctile
$0.15
95th Pctile
$2.52
Ann. Volatility
84.3%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Steven S. Williamson
Former Chief Executive Officer
$493,462 $2,259,390 $4,196,408
Glendon E. French
Chief Executive Officer
$116,186 $3,224,000 $3,543,520
Derrick Sung Operating
rating Officer and Chief Financial Officer
$83,333 $2,668,000 $2,951,391
Mehul Joshi Financial
ief Financial Officer
$381,199 $1,193,760 $1,983,761
David Lehman Counsel
Counsel
$472,400 $1,193,760 $1,710,404

CEO Pay Ratio

12:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $4,196,408
Avg Employee Cost (SGA/emp): $342,267
Employees: 296

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
296
+1.7% YoY
Revenue / Employee
$305,733
Rev: $90,497,000
Profit / Employee
$-182,443
NI: $-54,003,000
SGA / Employee
$342,267
Avg labor cost proxy
R&D / Employee
$65,848
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -15.4% -19.9% -23.2% -24.8% -25.6% -27.5% -33.9% -34.0% -34.9% -35.3% -44.7% -43.1% -42.5% -41.9% -55.3% -55.9% -55.8% -55.6% -77.2% -76.1% -76.05%
ROA -13.2% -17.0% -19.5% -20.8% -21.5% -23.1% -27.5% -27.5% -28.2% -28.6% -32.8% -31.6% -31.2% -30.7% -33.1% -33.5% -33.4% -33.3% -37.0% -36.4% -36.43%
ROIC -1.3% -1.6% -94.2% -1.0% -1.0% -1.1% -1.2% -1.3% -1.3% -1.3% -1.1% -1.1% -1.1% -1.1% -1.1% -1.1% -1.1% -1.1% -1.0% -1.0% -1.02%
ROCE -13.5% -17.5% -21.8% -23.4% -24.1% -26.0% -32.8% -32.6% -33.1% -33.1% -36.9% -35.3% -34.7% -34.2% -38.7% -40.4% -40.3% -40.3% -47.8% -45.8% -45.85%
Gross Margin 74.0% 73.4% 74.8% 75.2% 74.7% 75.2% 72.5% 72.9% 74.1% 73.7% 74.2% 74.1% 73.7% 73.7% 74.0% 72.5% 72.1% 74.7% 77.6% 77.9% 77.94%
Operating Margin -1.0% -73.6% -90.2% -1.5% -1.0% -1.0% -94.8% -1.1% -95.6% -85.9% -72.2% -77.1% -75.2% -69.3% -56.5% -64.6% -62.0% -66.9% -43.8% -62.9% -62.94%
Net Margin -1.1% -76.8% -94.9% -1.5% -1.0% -1.0% -92.6% -1.1% -94.2% -84.3% -72.0% -72.9% -73.7% -69.4% -55.4% -64.1% -63.6% -64.9% -46.1% -66.3% -66.33%
EBITDA Margin -1.0% -73.3% -85.8% -1.4% -1.0% -1.0% -86.2% -96.8% -86.0% -76.6% -64.1% -64.5% -67.1% -62.2% -55.2% -64.6% -58.3% -59.4% -43.8% -61.9% -61.87%
FCF Margin -99.9% -92.5% -93.1% -1.0% -91.4% -92.9% -86.6% -75.9% -68.7% -61.4% -55.9% -52.0% -47.3% -43.9% -39.4% -39.2% -35.4% -35.6% -36.3% -33.3% -33.27%
OCF Margin -94.8% -85.3% -85.5% -93.6% -84.4% -88.5% -84.1% -74.5% -67.7% -60.2% -54.8% -50.4% -45.2% -41.9% -37.6% -37.7% -34.4% -35.0% -35.8% -33.1% -33.09%
ROE 3Y Avg snapshot only -71.50%
ROE 5Y Avg snapshot only -55.94%
ROA 3Y Avg snapshot only -36.42%
ROIC 3Y Avg snapshot only -75.15%
ROIC Economic snapshot only -37.83%
Cash ROA snapshot only -22.66%
Cash ROIC snapshot only -72.39%
CROIC snapshot only -72.79%
NOPAT Margin snapshot only -46.44%
Pretax Margin snapshot only -59.37%
R&D / Revenue snapshot only 22.17%
SGA / Revenue snapshot only 1.12%
SBC / Revenue snapshot only 5.83%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -45.73 -29.17 -24.15 -17.57 -10.15 -10.75 -5.35 -7.13 -8.19 -6.43 -8.04 -6.10 -4.27 -5.70 -4.71 -4.71 -1.83 -1.17 -1.69 -1.02 -1.220
P/S Ratio 50.84 29.45 24.27 18.28 10.53 11.93 5.87 7.32 8.17 6.07 7.13 4.91 3.22 4.11 3.17 3.07 1.15 0.72 1.01 0.61 0.739
P/B Ratio 7.03 5.80 6.08 4.73 2.82 3.21 2.05 2.73 3.22 2.56 4.14 3.03 2.09 2.75 3.09 3.13 1.21 0.77 1.69 1.00 1.419
P/FCF -50.89 -31.84 -26.06 -18.00 -11.53 -12.83 -6.78 -9.64 -11.90 -9.89 -12.74 -9.44 -6.81 -9.36 -8.05 -7.85 -3.25 -2.03 -2.78 -1.83 -1.835
P/OCF
EV/EBITDA -41.36 -25.61 -22.15 -15.44 -7.72 -8.56 -3.54 -5.53 -6.81 -4.98 -7.56 -5.35 -3.29 -4.89 -4.25 -4.12 -1.09 -0.39 -1.52 -0.82 -0.819
EV/Revenue 44.30 24.85 21.10 15.20 7.56 8.97 3.70 5.28 6.25 4.27 6.02 3.87 2.24 3.15 2.63 2.56 0.65 0.23 0.86 0.46 0.456
EV/EBIT -40.86 -25.25 -21.51 -14.94 -7.45 -8.25 -3.45 -5.31 -6.54 -4.78 -7.25 -5.18 -3.19 -4.73 -4.12 -4.00 -1.06 -0.38 -1.49 -0.81 -0.807
EV/FCF -44.34 -26.88 -22.65 -14.97 -8.28 -9.65 -4.27 -6.96 -9.10 -6.96 -10.77 -7.44 -4.72 -7.18 -6.69 -6.53 -1.85 -0.65 -2.37 -1.37 -1.372
Earnings Yield -2.2% -3.4% -4.1% -5.7% -9.9% -9.3% -18.7% -14.0% -12.2% -15.6% -12.4% -16.4% -23.4% -17.5% -21.2% -21.2% -54.7% -85.6% -59.0% -98.4% -98.45%
FCF Yield -2.0% -3.1% -3.8% -5.6% -8.7% -7.8% -14.7% -10.4% -8.4% -10.1% -7.9% -10.6% -14.7% -10.7% -12.4% -12.7% -30.8% -49.2% -35.9% -54.5% -54.50%
Price/Tangible Book snapshot only 1.044
EV/Gross Profit snapshot only 0.604
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 19.96 19.96 11.85 11.85 11.85 11.85 9.14 9.14 9.14 9.14 6.50 6.50 6.50 6.50 5.58 5.58 5.58 5.58 5.07 5.07 5.069
Quick Ratio 19.10 19.10 10.92 10.92 10.92 10.92 8.35 8.35 8.35 8.35 5.77 5.77 5.77 5.77 4.88 4.88 4.88 4.88 4.28 4.28 4.280
Debt/Equity 0.12 0.12 0.14 0.14 0.14 0.14 0.16 0.16 0.16 0.16 0.35 0.35 0.35 0.35 0.66 0.66 0.66 0.66 1.04 1.04 1.042
Net Debt/Equity -0.90 -0.90 -0.79 -0.79 -0.79 -0.79 -0.76 -0.76 -0.76 -0.76 -0.64 -0.64 -0.64 -0.64 -0.52 -0.52 -0.52 -0.52 -0.25 -0.25 -0.252
Debt/Assets 0.10 0.10 0.11 0.11 0.11 0.11 0.13 0.13 0.13 0.13 0.23 0.23 0.23 0.23 0.35 0.35 0.35 0.35 0.44 0.44 0.436
Debt/EBITDA -0.81 -0.63 -0.57 -0.54 -0.52 -0.49 -0.44 -0.44 -0.44 -0.44 -0.76 -0.78 -0.80 -0.81 -1.09 -1.04 -1.04 -1.04 -1.10 -1.14 -1.143
Net Debt/EBITDA 6.11 4.73 3.33 3.12 3.03 2.82 2.08 2.13 2.10 2.10 1.38 1.43 1.46 1.48 0.87 0.83 0.83 0.83 0.27 0.28 0.277
Interest Coverage -49.15 -48.88 -57.28 -62.75 -63.51 -62.34 -53.94 -39.68 -27.85 -21.58 -17.64 -15.39 -15.04 -14.80 -15.26 -16.42 -16.83 -17.27 -16.55 -14.95 -14.949
Equity Multiplier 1.17 1.17 1.22 1.22 1.22 1.22 1.26 1.26 1.26 1.26 1.50 1.50 1.50 1.50 1.90 1.90 1.90 1.90 2.39 2.39 2.389
Cash Ratio snapshot only 3.490
Debt Service Coverage snapshot only -14.721
Cash to Debt snapshot only 1.242
FCF to Debt snapshot only -0.523
Defensive Interval snapshot only 252.0 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.12 0.17 0.19 0.20 0.21 0.21 0.25 0.27 0.28 0.30 0.37 0.39 0.41 0.43 0.49 0.51 0.53 0.54 0.62 0.61 0.606
Inventory Turnover 0.80 1.12 0.95 0.95 0.98 0.96 0.89 0.98 1.04 1.12 1.15 1.21 1.28 1.32 1.30 1.38 1.45 1.45 1.43 1.33 1.325
Receivables Turnover 7.40 10.53 8.97 9.26 9.58 9.63 7.04 7.53 7.96 8.51 6.61 7.02 7.37 7.63 6.64 6.94 7.18 7.27 7.18 7.03 7.030
Payables Turnover 5.81 8.21 8.37 8.40 8.63 8.52 8.26 9.02 9.58 10.35 11.07 11.65 12.27 12.71 8.22 8.72 9.16 9.19 6.04 5.61 5.614
DSO 49 35 41 39 38 38 52 48 46 43 55 52 50 48 55 53 51 50 51 52 51.9 days
DIO 458 325 386 385 374 379 408 374 352 326 317 301 286 276 281 265 252 251 256 275 275.5 days
DPO 63 44 44 43 42 43 44 40 38 35 33 31 30 29 44 42 40 40 60 65 65.0 days
Cash Conversion Cycle 445 315 383 380 370 374 416 382 360 333 339 322 306 295 291 275 263 261 246 262 262.4 days
Fixed Asset Turnover snapshot only 4.373
Operating Cycle snapshot only 327.4 days
Cash Velocity snapshot only 1.265
Capital Intensity snapshot only 1.460
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3.9% 1.6% 65.3% 16.6% 10.8% 14.9% 17.3% 24.8% 28.0% 27.1% 26.3% 22.3% 22.0% 19.8% 18.2% 15.6% 8.0% 1.2% 1.23%
Net Income -4.2% -1.4% -54.3% -28.2% -21.1% -13.4% -12.8% -6.2% -3.3% 0.4% 4.4% 6.7% 7.3% 2.8% 1.6% 0.6% 4.2% 6.8% 6.80%
EPS -3.8% -1.3% -50.3% -25.7% -18.7% -11.1% -10.3% -3.6% -0.6% 3.1% 7.1% 9.5% 9.1% 6.0% 4.7% 4.7% 9.5% 11.1% 11.12%
FCF -4.7% -1.8% -51.2% -17.2% -3.0% 14.1% 11.8% 17.6% 17.3% 12.9% 13.0% 12.6% 14.1% 9.7% 11.7% 6.2% 0.3% 14.0% 14.02%
EBITDA -4.2% -1.3% -51.3% -26.0% -21.5% -11.5% -9.8% -2.2% 2.2% 3.7% 6.6% 8.2% 5.2% -2.8% -4.4% -6.3% 1.5% 9.2% 9.22%
Op. Income -4.1% -1.3% -51.2% -27.3% -24.0% -17.6% -17.6% -11.1% -5.6% -1.2% 3.5% 7.1% 6.8% 3.9% 3.9% 1.8% 7.0% 9.8% 9.83%
OCF Growth snapshot only 11.12%
Asset Growth snapshot only -20.61%
Equity Growth snapshot only -36.93%
Debt Growth snapshot only -0.19%
Shares Change snapshot only 4.86%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 91.2% 56.4% 34.8% 21.2% 20.1% 20.5% 20.5% 20.8% 19.0% 15.5% 15.54%
Revenue 5Y 55.9% 35.9% 35.94%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y 92.7% 58.0% 35.6% 21.8% 20.2% 20.1% 19.8% 19.9% 19.0% 16.4% 16.44%
Gross Profit 5Y 56.8% 37.3% 37.32%
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y -12.3% -12.3% -12.3% -12.3% -11.5% -11.5% -11.5% -11.5% -12.6% -12.6% -12.60%
Assets 5Y -13.3% -13.3% -13.29%
Equity 3Y -19.4% -19.4% -19.4% -19.4% -23.7% -23.7% -23.7% -23.7% -29.4% -29.4% -29.43%
Book Value 3Y -22.7% -21.8% -21.5% -21.4% -25.4% -25.8% -25.8% -26.1% -31.8% -32.0% -31.95%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.84 0.89 0.95 0.98 0.88 0.93 0.98 0.98 0.96 0.98 0.99 1.00 0.97 0.95 0.950
Earnings Stability 0.90 0.89 0.93 0.91 0.79 0.74 0.71 0.53 0.61 0.59 0.55 0.35 0.47 0.42 0.417
Margin Stability 0.98 0.98 0.99 0.99 0.99 0.98 0.99 0.99 1.00 1.00 0.99 0.99 0.99 0.98 0.982
Rev. Growth Consistency 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.92 0.95 0.95 0.98 0.99 1.00 0.98 0.97 0.97 0.99 0.99 1.00 0.98 0.97 0.973
Earnings Smoothness
ROE Trend -0.24 -0.20 -0.18 -0.15 -0.20 -0.17 -0.15 -0.13 -0.21 -0.23 -0.22 -0.22 -0.41 -0.40 -0.402
Gross Margin Trend 0.01 0.01 0.00 -0.01 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.01 -0.00 0.00 0.02 0.017
FCF Margin Trend 0.00 0.22 0.27 0.31 0.34 0.37 0.33 0.33 0.32 0.25 0.23 0.17 0.11 0.12 0.123
Sustainable Growth Rate
Internal Growth Rate
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.85 0.84 0.85 0.90 0.81 0.80 0.77 0.73 0.68 0.64 0.62 0.63 0.60 0.58 0.56 0.58 0.55 0.57 0.60 0.55 0.551
FCF/OCF 1.05 1.08 1.09 1.09 1.08 1.05 1.03 1.02 1.01 1.02 1.02 1.03 1.05 1.05 1.05 1.04 1.03 1.02 1.01 1.01 1.005
FCF/Net Income snapshot only 0.554
CapEx/Revenue 5.1% 7.2% 7.6% 8.0% 7.0% 4.4% 2.5% 1.4% 0.9% 1.2% 1.2% 1.6% 2.1% 1.9% 1.7% 1.5% 1.0% 0.6% 0.5% 0.2% 0.18%
CapEx/Depreciation snapshot only 0.215
Accruals Ratio -0.02 -0.03 -0.03 -0.02 -0.04 -0.05 -0.06 -0.08 -0.09 -0.10 -0.13 -0.12 -0.13 -0.13 -0.15 -0.14 -0.15 -0.14 -0.15 -0.16 -0.164
Sloan Accruals snapshot only -0.212
Cash Flow Adequacy snapshot only -183.114
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio
FCF Payout Ratio
Total Payout Ratio
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -12.7% -15.4% -0.0% 0.0% 0.0% 0.0% -0.1% -0.0% -0.1% -0.1% -0.0% -0.1% -0.0% -0.0% -0.0% -0.0% -0.0% -0.0% -0.1% -0.7% -0.69%
Total Shareholder Return -12.7% -15.4% -0.0% 0.0% 0.0% 0.0% -0.1% -0.0% -0.1% -0.1% -0.0% -0.1% -0.0% -0.0% -0.0% -0.0% -0.0% -0.0% -0.1% -0.7% -0.69%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.01 1.01 1.01 1.00 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.012
Interest Burden (EBT/EBIT) 1.02 1.02 1.02 1.02 1.02 1.02 1.02 1.03 1.04 1.05 1.06 1.06 1.07 1.07 1.04 1.01 1.01 1.01 1.02 1.05 1.050
EBIT Margin -1.08 -0.98 -0.98 -1.02 -1.02 -1.09 -1.07 -0.99 -0.95 -0.89 -0.83 -0.75 -0.70 -0.67 -0.64 -0.64 -0.62 -0.61 -0.58 -0.57 -0.566
Asset Turnover 0.12 0.17 0.19 0.20 0.21 0.21 0.25 0.27 0.28 0.30 0.37 0.39 0.41 0.43 0.49 0.51 0.53 0.54 0.62 0.61 0.606
Equity Multiplier 1.17 1.17 1.19 1.19 1.19 1.19 1.24 1.24 1.24 1.24 1.36 1.36 1.36 1.36 1.67 1.67 1.67 1.67 2.09 2.09 2.088
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-0.96 $-1.23 $-1.33 $-1.41 $-1.45 $-1.55 $-1.58 $-1.57 $-1.60 $-1.61 $-1.59 $-1.52 $-1.49 $-1.45 $-1.44 $-1.43 $-1.42 $-1.39 $-1.30 $-1.27 $-1.27
Book Value/Share $6.27 $6.20 $5.27 $5.25 $5.22 $5.20 $4.12 $4.10 $4.07 $4.04 $3.08 $3.06 $3.04 $3.01 $2.19 $2.15 $2.13 $2.10 $1.31 $1.29 $1.09
Tangible Book/Share $6.20 $6.13 $5.20 $5.18 $5.15 $5.13 $4.05 $4.03 $4.01 $3.97 $3.02 $3.00 $2.98 $2.95 $2.13 $2.09 $2.08 $2.04 $1.25 $1.24 $1.24
Revenue/Share $0.87 $1.22 $1.32 $1.36 $1.40 $1.40 $1.44 $1.53 $1.60 $1.70 $1.79 $1.89 $1.97 $2.02 $2.14 $2.19 $2.25 $2.24 $2.19 $2.11 $2.11
FCF/Share $-0.87 $-1.13 $-1.23 $-1.38 $-1.28 $-1.30 $-1.24 $-1.16 $-1.10 $-1.04 $-1.00 $-0.98 $-0.93 $-0.89 $-0.84 $-0.86 $-0.80 $-0.80 $-0.79 $-0.70 $-0.70
OCF/Share $-0.82 $-1.04 $-1.13 $-1.27 $-1.18 $-1.24 $-1.21 $-1.14 $-1.09 $-1.02 $-0.98 $-0.95 $-0.89 $-0.85 $-0.81 $-0.83 $-0.77 $-0.78 $-0.78 $-0.70 $-0.70
Cash/Share $6.43 $6.36 $4.91 $4.89 $4.87 $4.84 $3.78 $3.76 $3.73 $3.70 $3.05 $3.03 $3.01 $2.98 $2.59 $2.54 $2.52 $2.48 $1.69 $1.67 $1.47
EBITDA/Share $-0.93 $-1.19 $-1.26 $-1.34 $-1.37 $-1.46 $-1.50 $-1.46 $-1.47 $-1.46 $-1.43 $-1.37 $-1.34 $-1.30 $-1.33 $-1.36 $-1.35 $-1.33 $-1.24 $-1.18 $-1.18
Debt/Share $0.76 $0.75 $0.72 $0.72 $0.72 $0.71 $0.65 $0.65 $0.65 $0.64 $1.08 $1.07 $1.06 $1.05 $1.44 $1.41 $1.40 $1.38 $1.36 $1.35 $1.35
Net Debt/Share $-5.68 $-5.61 $-4.19 $-4.17 $-4.15 $-4.13 $-3.12 $-3.11 $-3.09 $-3.06 $-1.97 $-1.96 $-1.94 $-1.93 $-1.15 $-1.13 $-1.12 $-1.10 $-0.33 $-0.33 $-0.33
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score -5.052
Altman Z-Prime snapshot only -10.857
Piotroski F-Score 2 2 3 3 3 3 2 2 2 2 3 3 3 3 3 2 2 3 3 3 3
Beneish M-Score -0.67 -0.66 -0.72 -0.75 -2.50 -2.51 -2.62 -2.68 -2.57 -2.51 -2.55 -2.57 -3.42 -3.39 -3.45 -3.46 -3.15 -3.26 -3.261
Ohlson O-Score snapshot only -4.348
ROIC (Greenblatt) snapshot only -49.16%
Net-Net WC snapshot only $0.63
EVA snapshot only $-45171340.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only B
Credit Score 60.43 60.34 60.52 60.69 62.44 62.57 48.34 63.14 63.87 59.93 48.23 37.04 31.79 36.86 29.95 29.90 29.88 29.68 28.01 27.67 27.667
Credit Grade snapshot only 15
Credit Trend snapshot only -2.237
Implied Spread (bps) snapshot only 750.000
Industry Credit Rank snapshot only 18
Sector Credit Rank snapshot only 16

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms